In draft recommendations, the guidelines body included the stool-based DNA test as an alternative screen strategy for colorectal cancer, a move the company did not expect.
In developing the recommendations, the expert panel attempted to keep up with the fast-moving advances in oncology.
With these five recommendations, ACMG is hoping to spur evidence-based and cost-effective genetic testing.
The Chinese guideline recommends the use of the Septin-9 DNA methylation assay as the standard of care for early colorectal cancer screening.
The draft document, which includes recommendations on which molecular tests labs should perform, on what samples, and with what analytical specifications, is available for comment until April 22.
The workgroup has created standard categories for variant classification and has outlined a process for mitigating classification disagreements among labs.
While ACMG recommends the review of variants in 56 genes for anyone undergoing large-scale genomic testing, the AMP report points out that doing so requires a significant effort on the part of laboratories.
The scientific organizations are revisiting the topic of molecular testing for lung cancer patients just a year and a half after releasing the initial guidelines.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.